About: Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children
Creator	Li, Han Wang, Jun Li, Ying Yuan, Bin Lu, Chao Zhao, Xia Gan, Weihua Gu, Jianhui Luo, Peiliang Miao, Hongjun Tian, Man Wang, Shouchuan Wu, Mingfu Yao, Yinying Zhao, Deyu
Source	Medline; PMC
abstract	Since the outbreak of novel coronavirus infection pneumonia in Wuhan City, China, in late 2019, such cases have been gradually reported in other parts of China and abroad. Children have become susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) because of their immature immune function. As the outbreak has progressed, more cases of novel coronavirus infection/pneumonia in children have been reported. Compared with adults, the impact of SARS-CoV-2 infection in children is less severe, with a lower incidence and susceptibility in children, which results in fewer children being tested, thereby underestimating the actual number of infections. Therefore, strengthening the diagnosis of the disease is particularly important for children, and early and clear diagnosis can determine treatment strategies and reduce the harm caused by the disease to children. According to the Novel Coronavirus Infection Pneumonia Diagnosis and Treatment Standards (trial version 7) issued by National Health Committee and the latest diagnosis and treatment strategies for novel coronavirus infection pneumonia in children, this review summarizes current strategies on diagnosis and treatment of SARS-CoV-2 infection in children.
has issue date	2020-08-06(xsd:dateTime)
bibo:doi	10.1007/s10096-020-03973-x
bibo:pmid	32761481
has license	cc-by
sha1sum (hex)	4c382f71807795a8bd3b47a12eb3a4b5e2797975
schema:url	https://doi.org/10.1007/s10096-020-03973-x
resource representing a document's title	Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children
has PubMed Central identifier	PMC7406700
has PubMed identifier	32761481
schema:publication	Eur J Clin Microbiol Infect Dis
resource representing a document's body	covid:4c382f71807795a8bd3b47a12eb3a4b5e2797975#body_text
is schema:about of	named entity 'Coronavirus' named entity 'tested' named entity 'National Health' named entity 'incidence' named entity 'late' named entity 'gradually' named entity 'parts' named entity 'According' named entity 'diagnosis' named entity 'SARS-CoV-2' named entity 'REDUCE' named entity 'IMPORTANT' named entity 'THEIR' named entity 'OUTBREAK' named entity 'RESULTS' named entity 'susceptibility' named entity 'current' named entity 'Diagnosis' named entity 'diagnosis' named entity 'infection' named entity 'severe' named entity 'progressed' named entity 'SARS-CoV-2' named entity 'infection' named entity 'immune function' named entity 'pneumonia' named entity 'infection' named entity 'coronavirus infection' named entity 'SARS-CoV-2' named entity 'organ' named entity 'bat' named entity 'runny nose' named entity 'nasal cannula' named entity 'chloroquine' named entity 'Serum' named entity 'glucocorticoids' named entity 'SARS-CoV-2' named entity 'Fever' named entity 'sore throat' named entity 'lungs' named entity 'white blood cell count' named entity 'antiviral drug' named entity 'GGO' named entity 'COVID-19' named entity '8 days' named entity 'China' named entity 'anti-influenza' named entity 'interferon-beta' named entity 'anxiety' named entity 'Fever' named entity 'pneumonia' named entity 'CD8 +' named entity 'tocilizumab' named entity 'fatigue' named entity 'SARS' named entity 'respiratory distress' named entity 'high fever' named entity 'critically ill patients' named entity 'Immunotherapy' named entity 'D-dimer' named entity 'vaccine' named entity 'nucleic acid test' named entity 'aerosol' named entity 'COVID' named entity 'cytokine storms' named entity 'epidemiological' named entity 'human infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software